# ZITUVIMET XR

NDC: 70771-1879
Generic name: sitagliptin and metformin hydrochloride
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20241031

FDA application: NDA216778

## Active ingredients

- METFORMIN HYDROCHLORIDE: 500 mg/1
- SITAGLIPTIN: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1879"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1879
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4bade493-499e-434a-97a0-26ca68917623